Shardul Amarchand Mangaldas & Co
Shardul Amarchand Mangaldas & Co primarily works with domestic and global pharma companies on regulatory compliance matters, including DCA licensing, manufacturing, and distribution, as well as working with e-commerce and medical devices clients on regulatory developments, commercial operations, and clinical trials. The firm also has notable cross-border transactional expertise in the life sciences space, advising private equity investors on a range of deals, including distressed acquisitions. Key names in the team include Mumbai’s Iqbal Khan and New Dehli-based Puja Sondhi, both experienced advisors on M&A, PE, and VC deals across the space.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Deep understanding of the sector; Investment into the understanding of market sectoral practices; Excellent cross-functional knowledge; tremendous client service and responsiveness.’
Key clients
- Biocon Biologics Limited
- Trivitron Healthcare
- Apollo Hospitals Enterprise Limited (AHEL), Apollo Healthco Limited (AHL) & Apollo Pharmacies Limited
- Advent International Corporation
- Curefit Healthcare Private Limited
- LR India Holdings Limited and Alpha Wave Incubation LP
- TPG Growth III SF Pte. Ltd.
- Dr. Agarwal’s Health Care Limited
- LeapFrog Investments Group Limited
- MMS Group (acting through its UK counsel, DWF Law LLP)
- UTI Multi Opportunities Fund I and UTI Structured Debt Opportunities Fund II
- Eris Lifesciences Limited (Eris)
Work highlights
- Advised Advent on the acquisition of Suven Pharmaceuticals Limited.